» Articles » PMID: 38801547

Radiomics Features of the Cardiac Blood Pool to Indicate Hemodynamic Changes in Pulmonary Hypertension (PH) Due to Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Overview
Publisher Springer
Specialty Radiology
Date 2024 May 27
PMID 38801547
Authors
Affiliations
Soon will be listed here.
Abstract

To test the hypothesis that cine MRI-derived radiomics features of the cardiac blood pool can represent hemodynamic characteristics of pulmonary hypertension-heart failure with preserved ejection fraction (PH-HFpEF). Nineteen PH-HFpEF patients (9 male, 57.8 ± 14.7 years) and 19 healthy controls (13 male, 50.3 ± 13.6 years) were enrolled. All participants underwent a cardiac MRI scan. One hundred and seven radiomics features (7 classes) of the blood pool in the left and right ventricles/atrium (LV/RV/LA/RA) were extracted from 4-chamber cine (2D images) at the stages of systole, rapid filling, diastasis, and atrial contraction within a cardiac cycle. For PH-HFpEF patients, features acquired from LV/LA were related to the pulmonary capillary wedge pressure (PCWP); features acquired from RV/RA were related to the mean pulmonary artery pressure (mPAP) using the Pearson correlation coefficient (r). Logistic regression, receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to test the capability of radiomics features in discriminating 2 subject groups. Features acquired from different chambers at various periods present diverse properties in representing hemodynamic indices of PH-HFpEF. Multiple radiomics features blood pool were significantly related to PCWP and/or mPAP (r: 0.4-0.679, p < 0.05). In addition, multiple features of blood pools acquired at various time points within a cardiac cycle can efficiently discriminate PH-HFpEF from controls (individual AUC: 0.7-0.864). Cine MRI-derived radiomics features of the cardiac blood pool have the potential to characterize hemodynamic abnormalities in the context of PH-HFpEF.

References
1.
Maurer M, Mancini D . HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward?. J Am Coll Cardiol. 2014; 64(6):550-2. DOI: 10.1016/j.jacc.2014.06.010. View

2.
Brittain E, Thenappan T, Huston J, Agrawal V, Lai Y, Dixon D . Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association. Circulation. 2022; 146(7):e73-e88. PMC: 9901193. DOI: 10.1161/CIR.0000000000001079. View

3.
Lam C, Roger V, Rodeheffer R, Borlaug B, Enders F, Redfield M . Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009; 53(13):1119-26. PMC: 2736110. DOI: 10.1016/j.jacc.2008.11.051. View

4.
Obokata M, Reddy Y, Borlaug B . The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?. Heart Fail Clin. 2019; 15(2):241-256. PMC: 6402610. DOI: 10.1016/j.hfc.2018.12.004. View

5.
Assadi H, Jones R, Swift A, Al-Mohammad A, Garg P . Cardiac MRI for the prognostication of heart failure with preserved ejection fraction: A systematic review and meta-analysis. Magn Reson Imaging. 2020; 76:116-122. PMC: 7819363. DOI: 10.1016/j.mri.2020.11.011. View